Shuqi Chi

469 total citations
19 papers, 346 citations indexed

About

Shuqi Chi is a scholar working on Molecular Biology, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Shuqi Chi has authored 19 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Obstetrics and Gynecology and 5 papers in Immunology. Recurrent topics in Shuqi Chi's work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and Endometriosis Research and Treatment (4 papers). Shuqi Chi is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and Endometriosis Research and Treatment (4 papers). Shuqi Chi collaborates with scholars based in China and United States. Shuqi Chi's co-authors include Hua Teng, Xing Zhou, Hongbo Wang, Hongbo Wang, Xiaoyan Xin, Yingchao Zhao, Rong Zhao, Dilu Feng, Yan Liu and Wei Zhang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Fertility and Sterility.

In The Last Decade

Shuqi Chi

18 papers receiving 346 citations

Peers

Shuqi Chi

IMMUN

Moito Iijima Japan

Shunyu Hou China

Chunyan Wei China

Bayley A. Jones United States

Hualei Bu China

Katharina Proestling Austria

Laura M S Seeber Netherlands

Sven Ackermann Germany

Daisuke Shintani Japan

Mitsutake Yano Japan

Moito Iijima Japan

Shuqi Chi

152 ×0.8

81 ×0.8

92 ×1.0

70 ×0.8

42 ×0.5

IMMUN

Citations per year, relative to Shuqi Chi Shuqi Chi (= 1×) peers Moito Iijima

Countries citing papers authored by Shuqi Chi

Since Specialization

Citations

This map shows the geographic impact of Shuqi Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuqi Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuqi Chi more than expected).

Fields of papers citing papers by Shuqi Chi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuqi Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuqi Chi. The network helps show where Shuqi Chi may publish in the future.

Co-authorship network of co-authors of Shuqi Chi

This figure shows the co-authorship network connecting the top 25 collaborators of Shuqi Chi. A scholar is included among the top collaborators of Shuqi Chi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuqi Chi. Shuqi Chi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Qi, Gonghua, et al.. (2025). Insufficient expression of COL6A1 promotes the development of early-onset severe preeclampsia by inhibiting the APJ/AKT signaling pathway. Cell Death Discovery. 11(1). 81–81. 2 indexed citations

Dong, Kejun, Shuqi Chi, Sitian Wei, et al.. (2023). lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer. Molecular Carcinogenesis. 63(3). 384–399. 6 indexed citations

Chi, Shuqi, et al.. (2020). Expression of angiogenic factor with G patch and FHA domains 1 (AGGF1) in placenta from patients with preeclampsia. Folia Histochemica et Cytobiologica. 58(2). 83–89.

Zhao, Rong, Dilu Feng, Yan Liu, et al.. (2020). Protein kinase CK2 participates in estrogen-mediated endothelial progenitor cell homing to endometriotic lesions through stromal cells in a stromal cell–derived factor-1– CXCR4-dependent manner. Fertility and Sterility. 113(5). 1067–1079.e5. 10 indexed citations

Liu, Yan, Rong Zhao, Shuqi Chi, et al.. (2019). UBE2C Is Upregulated by Estrogen and Promotes Epithelial–Mesenchymal Transition via p53 in Endometrial Cancer. Molecular Cancer Research. 18(2). 204–215. 94 indexed citations

Wu, Xiaoxiong, Hua Teng, Xiaoyan Xin, et al.. (2019). <p>NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer</p>. OncoTargets and Therapy. Volume 12. 6927–6936. 42 indexed citations

Liu, Yan, et al.. (2019). Prognostic value of distant metastatic sites in stage IV endometrial cancer: A SEER database study of 2948 women. International Journal of Gynecology & Obstetrics. 149(1). 16–23. 19 indexed citations

Chi, Shuqi, Yan Liu, Xing Zhou, et al.. (2018). Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B. Cancer Chemotherapy and Pharmacology. 83(2). 277–287. 22 indexed citations

Xin, Xiaoyan, Dilu Feng, Hua Teng, et al.. (2018). The suppressive role of calcium sensing receptor in endometrial cancer. Scientific Reports. 8(1). 1076–1076. 7 indexed citations

10.

Teng, Hua, Xiaoxiao Wang, Shuqi Chi, et al.. (2018). Estrogen‑related receptor γ promotes the migration and metastasis of endometrial cancer cells by targeting S100A4. Oncology Reports. 40(2). 823–832. 14 indexed citations

11.

Chi, Shuqi, et al.. (2018). NotOnlyLog: Mining Patch-Log Associations from Software Evolution History to Enhance Failure Diagnosis Capability. 10. 189–198. 1 indexed citations

12.

Liu, Yan, Hua Teng, Shuqi Chi, & Hongbo Wang. (2018). Identification of key pathways and genes in endometrial cancer using bioinformatics analyses. Oncology Letters. 15 indexed citations

13.

Chi, Shuqi, Hua Teng, Xiaoxiao Wang, et al.. (2017). Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis. Oncotarget. 8(45). 79061–79072. 16 indexed citations

14.

Liu, Yan, Zeming Liu, Qiuyang Zhao, et al.. (2017). Propensity score matching analysis of the prognosis for the rare insular subtype of thyroid cancer based on SEER database. Oncotarget. 8(60). 101623–101633. 6 indexed citations

15.

Chi, Shuqi, Hua Teng, Xiaoxiao Wang, et al.. (2017). Correction: Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis. Oncotarget. 8(59). 100957–100957. 1 indexed citations

16.

Teng, Hua, Xiaoyan Xin, Liqiong Cai, et al.. (2016). S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation. Oncology Reports. 35(6). 3419–3426. 13 indexed citations

17.

Xin, Xiaoyan, et al.. (2016). Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis. PLoS ONE. 11(11). e0166658–e0166658. 51 indexed citations

18.

Teng, Hua, et al.. (2016). Altered expression of hormone receptor, integrin β3 and pinopode in the endometrium of luteal phase defect women. Gynecological Endocrinology. 33(4). 315–319. 5 indexed citations

19.

Teng, Hua, et al.. (2016). Prognostic significance of L1 cell adhesion molecule in cancer patients: A systematic review and meta-analysis. Oncotarget. 7(51). 85196–85207. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact